The Elevation in Preoperative Procalcitonin Is Associated with a Poor Prognosis for Patients Undergoing Resection for Colorectal Cancer

Autor: Tomoyuki Ueki, Masatsugu Kojima, Yoshihiro Endo, Hiroyuki Ohta, Toru Miyake, Tsuyoshi Yamaguchi, Masaji Tani, Eiji Mekata, Tomoharu Shimizu, Sachiko Kaida, Hiroya Iida
Rok vydání: 2020
Předmět:
Zdroj: Digestive Surgery. 38:80-86
ISSN: 1421-9883
0253-4886
Popis: Background:Procalcitonin (PCT) is a well-known marker for bacterial infection; however, the clinical significance of PCT in the long-term prognosis after colorectal cancer (CRC) surgery remains unclear.
Methods:This is a retrospective review of 277 patients that underwent CRC surgery to investigate the relationship between preoperative PCT, clinicopathological condition, cancer-specific overall survival (OS), and relapse-free survival (RFS).
Results:Median follow-up interval was 5.0 years in all patients. Thirty-six patients developed recurrence, and 46 patients died due to recurrences or metastases of CRC. Preoperative PCT levels were highest in Stage IV patients. The cancer-specific OS in patients with Stage IV/PCT ≤0.05 ng/mL was significantly higher than those with Stage IV/PCT >0.05 ng/mL (3 years survival; 42.3 vs. 14.3%, p = 0.0413). On multivariate analysis, gender, TNM classification, and PCT were identified as significant risk factors for cancer-specific OS in patients with Stage I-III CRC. The cancer-specific OS rate of these patients with PCT ≥0.08 ng/mL, compared with PCT
Conclusion:High preoperative PCT values in CRC patients appeared to be associated with poor OS but not RFS following surgical treatments.
Databáze: OpenAIRE